System uses ultraviolet light system to kills advanced viruses and bacteria in minutes.
In an effort to address the ever-present decontamination concerns and priorities surrounding CT scanners used to image patients who are suspected of or have tested positive for COVID-19, Canon Medical System revealed, this week, a mobile CT unit that offers a rapid cleaning system.
In most cases, based on industry guidance, a CT scanner has been decommissioned for roughly an hour between scanning patients to minimize the likelihood of viral transmission. According to a company statement, the Aquilion™ Prime SP CT system can cut the cleaning time down to minutes by using an automated ultraviolet light system.
“Imaging infectious disease patients is not a new phenomenon for medical providers. But, our customers are facing an unprecedented number of potentially contagious patients,” said Erin Angel, managing director of Canon Medical System’s CT Business Unit, in a statement. “Our deployable CT offerings with the addition of rapid UV-C decontamination will offer providers a unique solution to help improve their workflow and safety as they image infectious disease patients.”
Available as a modular or mobile footprint, the system can be isolated from other staff and patients, creating a safer environment for imaging patients who are suspected of having COVID-19. The decontamination system reduces bacteria, spores, and viruses and is effective against a myriad of advanced viral infectious diseases, according to the company statement.
The system is available on new deployable CT solutions, as well as existing fixed imaging suites.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.